M.-H. Lin et al. / Tetrahedron 69 (2013) 8263e8268
8267
TLC (Et2O/hexanes (1:4)) Rf¼0.67; 1H NMR (300 MHz, CDCl3)
d
2.64
5.64e5.78 (m, 1H), 7.42 (t, J¼7.5 Hz, 1H), 7.52e7.64 (m, 3H); 13C
(dd, J¼15.0, 7.2 Hz, 1H), 2.75 (d, J¼5.4 Hz, 1H), 2.87 (dd, J¼15.0,
NMR (75 MHz, CDCl3) d 38.7 (CH2), 54.7 (CH2), 58.3 (C), 112.3 (C),
7.2 Hz, 1H), 2.99 (d, J¼5.4 Hz, 1H), 5.06e5.16 (m, 2H), 5.70e5.84 (m,
118.4 (C), 119.0 (CH2), 129.0 (CH), 129.4 (CH), 130.2 (CH), 130.9 (CH),
131.7 (CH), 141.5 (C); IR (neat) 3068, 2232, 1484 cmꢁ1; EIMS m/z (rel
intensity) 185 (Mþ, 3), 154 (15), 130 (100), 116 (39); HRMS [M]þ for
1H), 7.24e7.39 (m, 5H); 13C NMR (75 MHz, CDCl3)
d 39.4 (CH2), 54.7
(CH2), 59.2 (C), 118.3 (CH2), 125.8 (CHꢀ2), 127.4 (CH), 128.2 (CHꢀ2),
132.6 (CH), 139.9 (C). These data are in agreement with those re-
ported in the literature.8a
C12H11NO: 185.0841, found 185.0833.
4.2.2.8. 2-Allyl-2-(3-bromophenyl)oxirane (3i). Following the
4.2.2.2. 2-Allyl-2-p-tolyloxirane (3b). Following the general pro-
general procedure, the title compound was obtained (182 mg, 76%).
cedure, the title compound was obtained (132 mg, 76%). An oil; TLC
An oil; TLC (Et2O/hexanes (1:4)) Rf¼0.75; 1H NMR (300 MHz, CDCl3)
(Et2O/hexanes(1:4))Rf¼0.70;1HNMR(300MHz,CDCl3)
d
2.32(s, 3H),
d
2.59 (dd, J¼15.0, 6.6 Hz, 1H), 2.70 (d, J¼5.1 Hz,1H), 2.85 (dd, J¼15.0,
2.62 (dd, J¼15.0, 7.5 Hz, 1H), 2.73 (d, J¼5.4 Hz, 1H), 2.87 (ddt, J¼15.0,
7.5,1.5Hz,1H), 2.97(d,J¼5.4Hz,1H), 5.04e5.14(m, 2H),5.69e5.83(m,
1H), 7.13 (d, J¼7.8 Hz, 2H), 7.25 (d, J¼7.8 Hz, 2H); 13C NMR (75 MHz,
7.5 Hz, 1H), 2.98 (d, J¼5.1 Hz, 1H), 5.07e5.15 (m, 2H), 5.66e5.79 (m,
1H), 7.15e7.39 (m, 4H); 13C NMR (75 MHz, CDCl3)
d
39.1 (CH2), 54.7
(CH2), 58.6 (C), 118.8 (CH2), 122.4 (C), 124.5 (CH), 128.9 (CH), 129.8
(CH), 130.5 (CH), 132.1 (CH), 142.3 (C); IR (neat) 3086, 2912,
1571 cmꢁ1; EIMS m/z (rel intensity) 239 (Mþ, 5), 183 (100), 169 (28),
128 (83); HRMS [M]þ for C11H11BrO: 237.9993, found 237.9988.
CDCl3) d 21.0 (CH3), 39.5 (CH2), 54.8 (CH2), 59.1 (C), 118.3 (CH2), 125.8
(CHꢀ2),128.9(CHꢀ2),132.8(CH),136.9(C),137.1 (C). These data arein
agreement with those reported in the literature.8a
4.2.2.3. 2-Allyl-2-(4-methoxyphenyl)oxirane (3c). Following the
general procedure, the title compound was obtained (143 mg, 75%).
An oil; TLC (Et2O/hexanes (1:4)) Rf¼0.50; 1H NMR (300 MHz, CDCl3)
4.2.2.9. 2-Allyl-2-(2,5-dimethoxyphenyl)oxirane (3k). Following
the general procedure, the title compound was obtained (161 mg,
73%). An oil; TLC (Et2O/hexanes (1:4)) Rf¼0.44; 1H NMR (300 MHz,
d
2.62 (dd, J¼14.7, 7.5 Hz, 1H), 2.73 (d, J¼5.4 Hz, 1H), 2.83 (ddt,
CDCl3)
d
2.50 (dd, J¼14.7, 7.5 Hz,1H), 2.69 (d, J¼5.1 Hz,1H), 2.84 (dd,
J¼14.7, 7.5, 1.2 Hz, 1H), 2.96 (d, J¼5.4 Hz, 1H), 3.76 (s, 3H), 5.05e5.15
(m, 2H), 5.70e5.84 (m, 1H), 6.85 (d, J¼8.7 Hz, 2H), 7.29 (d, J¼8.7 Hz,
J¼14.7, 7.5 Hz, 1H), 2.94 (d, J¼5.1 Hz, 1H), 3.71 (s, 3H), 3.77 (s, 3H),
4.97e5.04 (m, 2H), 5.62e5.76 (m, 1H), 6.74 (s, 2H), 6.89 (m, 1H); 13
NMR (75 MHz, CDCl3) 39.5 (CH2), 53.0 (CH2), 55.4 (CH3), 55.5
(CH3), 58.6 (C), 111.1 (CH), 113.3 (CH), 113.6 (CH), 117.7 (CH2), 129.4
C
2H); 13C NMR (75 MHz, CDCl3)
d
39.5 (CH2), 54.6 (CH2), 55.0 (CH3),
d
58.8 (C), 113.4 (CHꢀ2), 118.1 (CH2), 127.0 (CHꢀ2), 131.8 (C), 132.8
(CH), 158.8 (C); IR (neat) 3048, 2938, 1518 cmꢁ1; EIMS m/z (rel in-
tensity) 190 (Mþ, 15), 161 (56), 135 (100), 121 (38); HRMS [M]þ for
(C), 132.8 (CH), 150.8 (C), 153.1 (C); IR (neat) 2940, 2833, 1500 cmꢁ1
;
EIMS m/z (rel intensity) 220 (Mþ, 43), 191 (24), 165 (100), 121 (41);
C
12H14O2: 190.0994, found 190.0991.
HRMS [M]þ for C13H16O3: 220.1099, found 220.1093.
4.2.2.4. 2-Allyl-2-(4-bromophenyl)oxirane (3d). Following the
4.2.2.10. 2-Allyl-2-(4-nitrophenyl)oxirane (3l). Following the
general procedure, the title compound was obtained (137 mg, 67%).
An oil; TLC (Et2O/hexanes (1:4)) Rf¼0.37; 1H NMR (300 MHz, CDCl3)
general procedure, the title compound was obtained (189 mg, 79%).
An oil; TLC (Et2O/hexanes (1:4)) Rf¼0.62; 1H NMR (300 MHz, CDCl3)
d
2.57 (dd, J¼15.0, 7.2 Hz, 1H), 2.66 (d, J¼5.4 Hz, 1H), 2.83 (dd,
d
2.62 (dd, J¼15.0, 7.2 Hz, 1H), 2.72 (d, J¼5.1 Hz, 1H), 2.93 (dd,
J¼15.0, 6.6 Hz, 1H), 2.95 (d, J¼5.4 Hz, 1H), 5.05e5.13 (m, 2H),
J¼15.0, 7.2 Hz, 1H), 3.05 (d, J¼5.1 Hz, 1H), 5.08e5.15 (m, 2H),
5.65e5.79 (m, 1H), 7.21 (d, J¼8.4 Hz, 2H), 7.41 (d, J¼8.4 Hz, 2H); 13
C
5.65e5.79 (m, 1H), 7.51 (d, J¼7.2 Hz, 2H), 8.16 (d, J¼7.2 Hz, 2H); 13
C
NMR (75 MHz, CDCl3)
d
38.9 (CH2), 54.5 (CH2), 58.5 (C), 118.5 (CH2),
NMR (75 MHz, CDCl3) d 38.7 (CH2), 54.9 (CH2), 58.6 (C), 119.0 (CH2),
121.2 (C), 127.5 (CHꢀ2), 131.1 (CHꢀ2), 132.1 (CH), 138.9 (C). These
123.3 (CHꢀ2), 126.7 (CHꢀ2), 131.6 (CH), 147.0 (C), 147.3 (C); EIMS m/
z (rel intensity) 205 (Mþ, 2),164 (9), 150 (100), 128 (52); HRMS [M]þ
for C11H11NO3: 205.0739, found 205.0743. These data are in
agreement with those reported in the literature.14
data are in agreement with those reported in the literature.8a
4.2.2.5. 2-Allyl-2-(4-chlorophenyl)oxirane (3e). Following the
general procedure, the title compound was obtained (158 mg, 81%).
An oil; TLC (Et2O/hexanes (1:4)) Rf¼0.67; 1H NMR (300 MHz, CDCl3)
4.3. 3-Allylbenzofuran (3g)
d
2.59 (dd, J¼15.0, 7.2 Hz, 1H), 2.69 (d, J¼5.4 Hz, 1H), 2.84 (ddt,
J¼15.0, 7.2, 1.2 Hz, 1H), 2.98 (d, J¼5.4 Hz, 1H), 5.05e5.13 (m, 2H),
To a solution of 2g (257 mg, 1 mmol) in acetone (4 mL) was
added K2CO3 (414 mg, 3 mmol) at rt and the suspension was stirred
at rt for 3 h. CH2Cl2 (5 mL) and 10% aq NH4Cl (5 mL) were added. The
mixture was transferred to a separatory funnel and the aqueous
layer was extracted with CH2Cl2 (5 mLꢀ2). The organic layers were
combined, dried over MgSO4, and concentrated in a rotary evapo-
rator. The residue was dissolved in benzene (3.5 mL) and TsOH/H2O
(6 mg, 0.03 mmol) was added. The mixture was heated at reflux for
1 h and then the mixture was cooled to rt. Et2O (5 mL) and 10% aq
NaHCO3 (5 mL) were added. The mixture was transferred to a sep-
aratory funnel and the aqueous layer was extracted with Et2O
(5 mLꢀ2). The organic layers were combined, dried over MgSO4,
and concentrated in a rotary evaporator. The residue was purified
by silica-gel chromatography using Et2O/hexanes (1:10) as eluent
to give the product 3g (130 mg, 82%). An oil; TLC (hexanes) Rf¼0.5;
5.66e5.80 (m, 1H), 7.28 (br s, 4H); 13C NMR (75 MHz, CDCl3)
d
39.2
(CH2), 54.8 (CH2), 58.7 (C), 118.6 (CH2), 127.3 (CHꢀ2), 128.4 (CHꢀ2),
132.3 (CH), 133.2 (C), 138.4 (C). These data are in agreement with
those reported in the literature.8a
4.2.2.6. 2-Allyl-2-(naphthalen-2-yl)oxirane (3f). Following the
general procedure, the title compound was obtained (162 mg, 77%).
An oil; TLC (Et2O/hexanes (1:4)) Rf¼0.57; 1H NMR (300 MHz, CDCl3)
d
2.73 (dd, J¼15.0, 7.2 Hz, 1H), 2.84 (d, J¼5.4 Hz, 1H), 3.00 (ddt,
J¼15.0, 7.2, 1.2 Hz, 1H), 3.07 (d, J¼5.4 Hz, 1H), 5.06e5.19 (m, 2H),
5.74e5.88 (m, 1H), 7.43e7.50 (m, 3H), 7.80e7.85 (m, 4H); 13C NMR
(75 MHz, CDCl3) d 39.2 (CH2), 54.6 (CH2), 59.3 (C), 118.3 (CH2), 123.5
(CH), 124.8 (CH), 125.8 (CH), 126.0 (CH), 127.4 (CH), 127.7 (CH), 127.8
(CH), 132.5 (CH), 132.5 (C), 132.9 (C), 137.2 (C). These data are in
agreement with those reported in the literature.8a
1H NMR (300 MHz, CDCl3)
2H), 6.00e6.13 (m, 1H), 7.24e7.35 (m, 2H), 7.44e7.60 (m, 3H); 13C
NMR (75 MHz, CDCl3) 28.0 (CH2), 111.3 (CH), 116.3 (CH2), 118.3 (C),
d
3.46 (d, J¼7.8 Hz, 2H), 5.14e5.27 (m,
4.2.2.7. 3-(2-Allyloxiran-2-yl)benzonitrile (3h). Following the
general procedure, the title compound was obtained (156 mg, 84%).
An oil; TLC (Et2O/hexanes (1:4)) Rf¼0.35; 1H NMR (300 MHz, CDCl3)
d
119.7 (CH), 122.2 (CH), 124.1 (CH), 128.0 (C), 135.3 (CH), 141.5 (CH),
155.4 (C); EIMS m/z (rel intensity) 158 (Mþ, 100), 131 (60), 113 (16),
77 (15); HRMS [M]þ for C11H10O: 158.0732, found 158.0730. These
data are in agreement with those reported in the literature.13
d
2.60 (dd, J¼15.0, 6.6 Hz, 1H), 2.70 (d, J¼5.1 Hz, 1H), 2.87 (dd,
J¼15.0, 6.6 Hz, 1H), 3.02 (d, J¼5.1 Hz, 1H), 5.07e5.14 (m, 2H),